Authors: KELLOFF GJ CROWELL JA HAWK ET STEELE VE LUBET RA BOONE CW COVEY JM DOODY LA OMENN GS GREENWALD P HONG WK PARKINSON DR BAGHERI D BAXTER GT BLUNDEN M DOELTZ MK EISENHAUER KM JOHNSON K KNAPP GG LONGFELLOW DG MALONE WF NAYFIELD SG SEIFRIED HE SWALL LM SIGMAN CC

Citation: Gj. Kelloff et al., STRATEGY AND PLANNING FOR CHEMOPREVENTIVE DRUG DEVELOPMENT - CLINICALDEVELOPMENT PLANS-II, Journal of cellular biochemistry, 1996, pp. 54-71

Authors: KELLOFF GJ CROWELL JA HAWK ET STEELE VE LUBET RA BOONE CW COVEY JM DOODY LA OMENN GS GREENWALD P HONG WK PARKINSON DR BAGHERI D BAXTER GT BLUNDEN M DOELTZ MK EISENHAUER KM JOHNSON K KNAPP GG LONGFELLOW DG MALONE WF NAYFIELD SG SEIFRIED HE SWALL LM SIGMAN CC

Citation: Gj. Kelloff et al., CLINICAL DEVELOPMENT PLANS FOR CANCER CHEMOPREVENTIVE AGENTS, Journal of cellular biochemistry, 1996, pp. 72-321

Authors: KELLOFF GJ CROWELL JA BOONE CW STEELE VE LUBET RA GREENWALD P ALBERTS DS COVEY JM DOODY LA KNAPP GG NAYFIELD S PARKINSON DR PRASAD VK PROROK PC SAUSVILLE EA SIGMAN CC

Citation: Gj. Kelloff et al., STRATEGY AND PLANNING FOR CHEMOPREVENTIVE DRUG DEVELOPMENT - CLINICALDEVELOPMENT PLANS, Journal of cellular biochemistry, 1994, pp. 55-303